ELEV
Goldman Sachs’s Elevation Oncology ELEV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82.3K | Buy |
224,159
+147,513
| +192% | +$54.2K | ﹤0.01% | 4917 |
|
|
2025
Q1 | $19.9K | Sell |
76,646
-1,575,077
| -95% | -$408K | ﹤0.01% | 4976 |
|
|
2024
Q4 | $929K | Sell |
1,651,723
-2,336,749
| -59% | -$1.31M | ﹤0.01% | 3960 |
|
|
2024
Q3 | $2.39M | Buy |
3,988,472
+3,484,341
| +691% | +$2.09M | ﹤0.01% | 3242 |
|
|
2024
Q2 | $1.36M | Sell |
504,131
-46,948
| -9% | -$127K | ﹤0.01% | 3437 |
|
|
2024
Q1 | $2.83M | Buy |
+551,079
| New | +$2.83M | ﹤0.01% | 2975 |
|
|
2023
Q4 | – | Sell |
-55,878
| Closed | -$37K | – | 4806 |
|
|
2023
Q3 | $37K | Buy |
+55,878
| New | +$37K | ﹤0.01% | 4513 |
|
|
2022
Q1 | – | Sell |
-10,294
| Closed | -$62K | – | 5779 |
|
|
2021
Q4 | $62K | Buy |
+10,294
| New | +$62K | ﹤0.01% | 5315 |
|
|
2021
Q3 | – | Sell |
-62,500
| Closed | -$848K | – | 5392 |
|
|
2021
Q2 | $848K | Buy |
+62,500
| New | +$848K | ﹤0.01% | 4127 |
|